Research
Micronutrients & recovery
Icosapent ethyl (pure EPA) reduces cardiovascular events in patients with Type 2 Diabetes and elevated triglycerides who are already on statin therapy.
If you have Type 2 Diabetes, high triglycerides, and are already taking a statin for cholesterol, ask your doctor about Icosapent Ethyl (Vascepa). This specific prescription omega-3 fatty acid has been shown to significantly reduce the risk of heart attack and stroke in patients like you. It is not the same as over-the-counter fish oil.
StrongSupportsVERY_HIGH confidence
The REDUCE-IT trial ... showed a 25% lower risk of subsequent CVD events on top of statin therapy in those with higher triglycerides (135 mg/dL or higher) and well-controlled LDL-C levels with a similar reduction in risk in those with (23%) and without (27%) DM
Why this rating
Based on the large REDUCE-IT trial.
Source
Cardiodiabetology: newer pharmacologic strategies for reducing cardiovascular disease risks
Nathan D. Wong · Canadian Journal of Physiology and Pharmacology · 2022
narrative_reviewCited 2×
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →